指南与共识关节外科

择期全关节置换术患者糖尿病药物的围手术期管理:当前指南与推荐综述

Perioperative Management of Diabetic Medications in Patients Undergoing Elective Total Joint Arthroplasty: A Review of Current Guidelines and Recommendations.
指南 / 共识 · J Arthroplasty · 2025-10-27

该综述评估了10类主要糖尿病药物的作用机制、不良反应及当前围手术期管理推荐,指出针对全关节置换术(TJA)的围手术期糖尿病药物管理文献仍缺乏,但已有许多在择期手术和TJA背景下合成的指南,并汇总了10类主要糖尿病药物的围手术期指南及当前可用的围手术期指南。

要点

  • TJA患者中糖尿病患病率持续上升,糖尿病易导致假体周围关节感染等重大并发症。
  • 综述评估了10类主要糖尿病药物的作用机制、不良反应及当前围手术期管理推荐。
  • 针对TJA的围手术期糖尿病药物管理文献仍缺乏,许多药物类别尚未在TJA背景下研究。

核心结论

  • 基于文献综述,作者汇总了10类主要糖尿病药物的围手术期指南及当前可用的围手术期指南。
  • 许多药物类别尚未在TJA背景下研究,作者希望该汇总能为骨科医生提供实用的临床指南和见解。

研究设计与样本

  • 综述评估了关于10类主要糖尿病药物的现有文献,包括其作用机制、不良反应及当前围手术期管理推荐。

主要发现

  • 针对TJA的围手术期糖尿病药物管理文献仍缺乏。
  • 已有许多在择期手术和TJA背景下为这些药物合成的指南。
  • 许多糖尿病药物类别尚未在TJA背景下研究。

临床怎么用

  • 作者希望该汇总能为骨科医生在术前管理和治疗糖尿病患者时提供实用的临床指南和见解。

局限性

  • 针对TJA的围手术期糖尿病药物管理文献仍缺乏。
  • 许多药物类别尚未在TJA背景下研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of diabetes in patients undergoing total joint arthroplasty (TJA) is steadily increasing. Diabetes predisposes patients to major complications such as prosthetic joint infection, which poses major challenges to the patient and surgeon. Therefore, careful perioperative glucose management in these patients is critical. Medications have been the mainstay in the management of diabetes; however, these medications are each associated with their unique risk profile in the perioperative period. METHODS: This review evaluated the available literature regarding the 10 main diabetic medication classes, their mechanism of action, adverse effects, and current perioperative management recommendations. RESULTS: Available literature addressing perioperative diabetic medication management in TJA is still lacking; however, there are still many guidelines that have been synthesized for these medications in both an elective surgery setting and within TJA. CONCLUSIONS: Based on this literature review, we provided a summation of the perioperative guidelines for the ten main diabetic drug classes and what the current available perioperative guidelines are. Many of these medication classes have not been studied yet in the setting of TJA. However, we hope this summation offers orthopaedic providers a practical clinical guideline and insight into managing and treating their diabetic patients preoperatively.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kumar J, Fawcett MA, Sherman CE, et al. Perioperative Management of Diabetic Medications in Patients Undergoing Elective Total Joint Arthroplasty: A Review of Current Guidelines and Recommendations. J Arthroplasty. 2025. PMID: 41161517. doi:10.1016/j.arth.2025.10.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。